How to treat myeloma

Myeloma is a malignant plasma cell disease in which tumor cells originate from plasma cells in the bone marrow, which are cells in the final functional stage of b lymphocyte development, so multiple myeloma can be classified as b lymphoma. Multiple myeloma is often accompanied by multiple osteolytic lesions, hypercalcemia, anemia, kidney damage. Since normal immunoglobulin production is suppressed, it is prone to various bacterial infections. The patient diagnosed with multiple myeloma is recommended to be treated with chemotherapy, thalidomide?, hematopoietic stem cell transplantation, etc. Bortezomib is the first choice at this stage. The side effects of this treatment are minor and the curative effect is good.